Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), a tech-enabled Medicare Advantage company, today announced the commencement of an underwritten public offering of
According to Benzinga Pro data, during Q2, Alignment Healthcare (NASDAQ:ALHC) posted sales of $366.47 million. Earnings were up 71.63%, but Alignment Healthcare still reported an overall loss of $11.58 million.
Albireo Pharma, Inc. (NASDAQ: ALBO) dropped 23.5% to $19.00 after the company reported worse-than-expected Q2 EPS results and filed for a mixed shelf of up to $400 million.